• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Sensus Healthcare Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    6/2/25 4:20:10 PM ET
    $SRTS
    Medical/Dental Instruments
    Health Care
    Get the next $SRTS alert in real time by email
    false 0001494891 0001494891 2025-05-27 2025-05-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

    ____________________

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the

    Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 27, 2025

     

    SENSUS HEALTHCARE, INC.

    (Exact name of registrant as specified in its charter)

    Delaware

     

    001-37714

     

    27-1647271

    (State of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)

    851 Broken Sound Pkwy., NW # 215, Boca Raton, Florida

     

    33487

    (Address of principal executive offices)   (Zip Code)

    Registrant's telephone number, including area code: (561) 922-5808

    _________________________________________________

    (Former Name or Former Address, if Changed Since Last Report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock, par value $0.01 per share SRTS Nasdaq Stock Market, LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

      

     

     

    SENSUS HEALTHCARE, INC.

    FORM 8-K

    CURRENT REPORT

    Item 5.07Submission of Matters to a Vote of Security Holders

     

    The Annual Meeting of Stockholders (the “Annual Meeting”) of Sensus Healthcare, Inc. (the “Company”) was held on May 27, 2025. Proxies for the Annual Meeting were solicited pursuant to Regulation 14A under the Securities Exchange Act of 1934, and there was no solicitation in opposition to the Company’s solicitation. The following summarizes all matters voted on at the Annual Meeting.

     

    1. Election of Director. Anthony Petrelli was elected as a Class I director for a three-year term to expire in 2028. The nominee was an incumbent director, no other person was nominated, and the nominee was elected. The tabulation of votes cast was as follows:

     

            For   Against   Abstention   Broker Non-Votes
    Anthony Petrelli       4,325,657   1,563,543   13,305   5,483,082

     

    2. Vote on Amendment of the Company’s 2017 Incentive Plan. Stockholders approved the amendment of the Company’s 2017 Incentive Plan to extend the term of such Plan and increase the number of shares that may be issued under such Plan. The tabulation of votes cast was as follows:

     

      For   Against   Abstention   Broker Non-Votes
      5,186,278   495,719   220,508   5,483,082

     

     

    3. Advisory Vote on Executive Compensation. Stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers for 2024. The tabulation of votes cast was as follows:

     

      For   Against   Abstention   Broker Non-Votes
      5,057,473   346,796   498,236   5,483,082

     

    4. Auditor Appointment Ratification. Stockholders ratified the appointment of Berkowitz Pollack Brant Advisors + CPAs, LLP as the Company’s independent registered public accountant for the fiscal year ended December 31, 2025. The tabulation of votes cast was as follows:

     

      For   Against   Abstention
      11,113,695   66,087   205,805

     

     

      

     

     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

      SENSUS HEALTHCARE, INC.
         
         
    Date: June 2, 2025 By: /s/ Javier Rampolla
        Javier Rampolla
        Chief Financial Officer
         

     

      

     

     

    Get the next $SRTS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SRTS

    DatePrice TargetRatingAnalyst
    1/31/2025$18.00Buy
    Lake Street
    11/15/2024$12.00 → $14.00Buy
    Maxim Group
    3/3/2022$12.00 → $13.00Buy
    HC Wainwright & Co.
    2/14/2022$10.00 → $12.00Buy
    HC Wainwright & Co.
    12/2/2021$9.00 → $10.00Buy
    HC Wainwright & Co.
    11/5/2021$7.00 → $9.00Buy
    HC Wainwright & Co.
    8/6/2021$6.00 → $7.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $SRTS
    Financials

    Live finance-specific insights

    See more
    • Sensus Healthcare Reports First Quarter 2025 Financial Results

      21 SRT systems shipped during the quarter; revenues of $8.3 million 65% increase in treatment volume from FDAs over preceding quarter Profitability forecast for the next three quarters and for the full year Conference call begins at 4:30 p.m. Eastern time today Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces financial results for the three months ended March 31, 2025. Highlights of the first quarter of 2025 include the following: Revenues were $8.3 million Net loss was $2.6 million, or $(0.16) per share Shi

      5/15/25 4:05:00 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15

      Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the company will report financial results for the first quarter of 2025 on Thursday, May 15, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Participants are encouraged to pre-register for the conference call using this link to receive a unique dial-in number to bypass the live operator. Participants may pre-register at any time, including up to and after the call sta

      5/1/25 8:00:00 AM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results

      Shipped a record 39 SRT systems during the quarter; revenues of $13.1 million Achieved fifth consecutive quarter of profitability; diluted EPS of $0.09 Conference call begins at 4:30 p.m. Eastern time today Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces financial results for the three and 12 months ended December 31, 2024. Highlights include the following: Revenues were $13.1 million for the fourth quarter and $41.8 million for the year, up 4% and 71% respectively, compared with the prior year Net income

      2/5/25 4:05:00 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care

    $SRTS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sensus Healthcare Reports First Quarter 2025 Financial Results

      21 SRT systems shipped during the quarter; revenues of $8.3 million 65% increase in treatment volume from FDAs over preceding quarter Profitability forecast for the next three quarters and for the full year Conference call begins at 4:30 p.m. Eastern time today Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces financial results for the three months ended March 31, 2025. Highlights of the first quarter of 2025 include the following: Revenues were $8.3 million Net loss was $2.6 million, or $(0.16) per share Shi

      5/15/25 4:05:00 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments

      Innovative SRT-100 Vision (IG-SRT) and SRT Vision Technologies allow dermatologists to treat non-melanoma skin cancer without surgery or patient downtime May is Skin Cancer Awareness Month and Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, is leveraging a wide range of activities to draw attention to the importance of prevention, early detection and treatment of the most common form of cancer that affects millions of people worldwide. Throughout the month of May, Sensus Healthcare is actively promoting skin cancer awareness

      5/1/25 4:30:00 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15

      Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the company will report financial results for the first quarter of 2025 on Thursday, May 15, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Participants are encouraged to pre-register for the conference call using this link to receive a unique dial-in number to bypass the live operator. Participants may pre-register at any time, including up to and after the call sta

      5/1/25 8:00:00 AM ET
      $SRTS
      Medical/Dental Instruments
      Health Care

    $SRTS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CHIEF FINANCIAL OFFICER Rampolla Javier bought $2,981 worth of shares (501 units at $5.95), increasing direct ownership by 1% to 40,745 units (SEC Form 4)

      4 - Sensus Healthcare, Inc. (0001494891) (Issuer)

      2/10/25 3:20:55 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • PRESIDENT AND GENERAL COUNSEL Sardano Michael bought $5,950 worth of shares (1,000 units at $5.95), increasing direct ownership by 0.87% to 115,839 units (SEC Form 4)

      4 - Sensus Healthcare, Inc. (0001494891) (Issuer)

      2/10/25 3:16:03 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care

    $SRTS
    SEC Filings

    See more
    • Sensus Healthcare Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Sensus Healthcare, Inc. (0001494891) (Filer)

      6/2/25 4:20:10 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • SEC Form SD filed by Sensus Healthcare Inc.

      SD - Sensus Healthcare, Inc. (0001494891) (Filer)

      5/30/25 4:05:32 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Sensus Healthcare Inc.

      SCHEDULE 13G/A - Sensus Healthcare, Inc. (0001494891) (Subject)

      5/22/25 4:13:39 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care

    $SRTS
    Leadership Updates

    Live Leadership Updates

    See more
    • Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments

      Innovative SRT-100 Vision (IG-SRT) and SRT Vision Technologies allow dermatologists to treat non-melanoma skin cancer without surgery or patient downtime May is Skin Cancer Awareness Month and Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, is leveraging a wide range of activities to draw attention to the importance of prevention, early detection and treatment of the most common form of cancer that affects millions of people worldwide. Throughout the month of May, Sensus Healthcare is actively promoting skin cancer awareness

      5/1/25 4:30:00 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • Sensus Healthcare Announces Retirement of Director Samuel O'Rear

      BOCA RATON, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Samuel O'Rear will not stand for reelection to the Company's Board of Directors at the Company's 2024 annual meeting of stockholders.  Mr. O'Rear has been a Director of Sensus Healthcare since 2012. As previously announced, on January 11, 2024 the Board of Directors of Sensus Healthcare appointed Michael J. Sardano, President and General Counsel of Sensus Healthcare, as a Director, effective today. "Sam has been inv

      2/1/24 8:00:00 AM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions

      BOCA RATON, Fla, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces the following promotions, all effective immediately: Vice President and General Counsel Michael J. Sardano has been promoted to President and General CounselSales Manager Christopher Machuzak has been promoted to Vice President of Sales for the West CoastSoutheast Regional Sales Manager Jeffrey Starling has been promoted to Vice President of Sales for the East Coast In addition, the Company announces the retirement of Steve Cohen, Executive Vice Pre

      1/31/22 4:05:00 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care

    $SRTS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Chow Carlton

      3 - Sensus Healthcare, Inc. (0001494891) (Issuer)

      6/10/25 5:33:41 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • CHIEF FINANCIAL OFFICER Rampolla Javier bought $2,981 worth of shares (501 units at $5.95), increasing direct ownership by 1% to 40,745 units (SEC Form 4)

      4 - Sensus Healthcare, Inc. (0001494891) (Issuer)

      2/10/25 3:20:55 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • PRESIDENT AND GENERAL COUNSEL Sardano Michael bought $5,950 worth of shares (1,000 units at $5.95), increasing direct ownership by 0.87% to 115,839 units (SEC Form 4)

      4 - Sensus Healthcare, Inc. (0001494891) (Issuer)

      2/10/25 3:16:03 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care

    $SRTS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Sensus Healthcare Inc. (Amendment)

      SC 13G/A - Sensus Healthcare, Inc. (0001494891) (Subject)

      2/6/24 12:27:47 PM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Sensus Healthcare Inc. (Amendment)

      SC 13G/A - Sensus Healthcare, Inc. (0001494891) (Subject)

      2/10/23 11:51:22 AM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Sensus Healthcare Inc. (Amendment)

      SC 13G/A - Sensus Healthcare, Inc. (0001494891) (Subject)

      2/7/22 8:30:08 AM ET
      $SRTS
      Medical/Dental Instruments
      Health Care

    $SRTS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on Sensus Healthcare with a new price target

      Lake Street initiated coverage of Sensus Healthcare with a rating of Buy and set a new price target of $18.00

      1/31/25 9:07:11 AM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • Maxim Group reiterated coverage on Sensus Healthcare with a new price target

      Maxim Group reiterated coverage of Sensus Healthcare with a rating of Buy and set a new price target of $14.00 from $12.00 previously

      11/15/24 8:09:06 AM ET
      $SRTS
      Medical/Dental Instruments
      Health Care
    • HC Wainwright & Co. reiterated coverage on Sensus Healthcare with a new price target

      HC Wainwright & Co. reiterated coverage of Sensus Healthcare with a rating of Buy and set a new price target of $13.00 from $12.00 previously

      3/3/22 6:32:52 AM ET
      $SRTS
      Medical/Dental Instruments
      Health Care